1. Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma
   Kaidong Liu et al, 2022, Molecular Oncology CrossRef
2. A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment
   Marlene Geyer et al, 2023, Cell Death Discovery CrossRef
3. The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
   Hai-Ling Gao et al, 2023, Frontiers in Pharmacology CrossRef
4. Integrative Network Pharmacology of Moringa oleifera Combined with Gemcitabine against Pancreatic Cancer
   Nursaffa Alisya Sahruddin et al, 2021, Processes CrossRef
5. ENHANCED ANTICANCER POTENCY OF GEMCITABINE IN COMBINATION WITH PROPOFOL IN PROSTATE CANCER
   Elanur AYDIN KARATAŞ et al, 2022, Hacettepe Journal of Biology and Chemistry CrossRef